Phase I Unit for Therapeutics Research
$238,436N01FY2016AINIH
Duke University, Durham NC
Investigators
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.
View original record on NIH RePORTER →